Clinical trials are the engine of medical progress.
But today, they still take a lot of time, are relatively expensive and aren’t built for flexibility.
In rare cancer, where time is limited and patient populations are small, traditional trials often struggle to deliver meaningful results.
Much of that comes down to infrastructure: Setting up studies takes months. Processes are manual. Data is fragmented and therefore hard to use.
Too much time and costs are simply lost to logistics, not science.
At Yamicc, we solve what slows more effective treatments for patients down.
We develop the digital infrastructure behind smarter research. Our Yamicc Platform automates routine work, supports multicenter trials and uses open standards so data can be reused across studies and hospitals. We do so by using AI tools for faster and easier writing of protocols, and have the technology to connect data of different structures. We have the expertise for automated data extraction and collection in hospitals systems.
That’s our expertise: building the system that makes faster, cheaper and more efficient trials possible.
This is how we accelerate: You and Me in Curing Cancer. Are you in?
